ArticleLeukemia2016

Activity of 8F4, a T-cell receptor-like anti-PR1/HLA-A2 antibody, against primary human AML in vivo.

A Sergeeva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.